tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CRMD Stock Latest News

P/E Steals: 3 Overlooked Stocks Ready to Surge Over 100% in 2026
Market NewsP/E Steals: 3 Overlooked Stocks Ready to Surge Over 100% in 2026
1d ago
DDI
BTBT
Cormedix: Near-Term Reimbursement Headwinds but Compelling Long-Term Upside Supports Buy Rating and $18 Target
PremiumRatings
Cormedix: Near-Term Reimbursement Headwinds but Compelling Long-Term Upside Supports Buy Rating and $18 Target
6d ago
CRMD
Cormedix: Market Overreaction to 2026 Guidance Creates Undervalued Buy Opportunity
PremiumRatings
Cormedix: Market Overreaction to 2026 Guidance Creates Undervalued Buy Opportunity
7d ago
CRMD
CorMedix price target lowered to $16 from $20 at Truist
PremiumThe Fly
CorMedix price target lowered to $16 from $20 at Truist
7d ago
CRMD
Midday Fly By: Defense stocks surge on Trump budget request
PremiumThe Fly
Midday Fly By: Defense stocks surge on Trump budget request
7d ago
F
AA
Cormedix Issues Strong Preliminary Q4 Results, Updates Outlook
PremiumCompany AnnouncementsCormedix Issues Strong Preliminary Q4 Results, Updates Outlook
8d ago
8K
CRMD
CorMedix sees FY26 revenue $300M-$320M
Premium
The Fly
CorMedix sees FY26 revenue $300M-$320M
8d ago
CRMD
CorMedix CEO Joseph Todisco signs extended employment contract
Premium
The Fly
CorMedix CEO Joseph Todisco signs extended employment contract
8d ago
CRMD
CorMedix appoints Mike Seckler as CCO
PremiumThe Fly
CorMedix appoints Mike Seckler as CCO
8d ago
CRMD
CorMedix sees Q4 revenue $127M, consensus $127.52M
PremiumThe Fly
CorMedix sees Q4 revenue $127M, consensus $127.52M
8d ago
CRMD
DefenCath’s Strong Clinical and Economic Profile Underpins Buy Rating Despite Anticipated 2026 Pricing Headwinds
PremiumRatings
DefenCath’s Strong Clinical and Economic Profile Underpins Buy Rating Despite Anticipated 2026 Pricing Headwinds
28d ago
CRMD
CorMedix announces interim results for DefenCath
PremiumThe Fly
CorMedix announces interim results for DefenCath
29d ago
CRMD
Cormedix’s Promising Outlook: Strong Financial Performance, Strategic Acquisition, and Growth Catalysts Justify Buy Rating
PremiumRatingsCormedix’s Promising Outlook: Strong Financial Performance, Strategic Acquisition, and Growth Catalysts Justify Buy Rating
2M ago
CRMD
CorMedix price target raised to $18 from $17 at H.C. Wainwright
Premium
The Fly
CorMedix price target raised to $18 from $17 at H.C. Wainwright
2M ago
CRMD
CorMedix Inc. Reports Strong Q3 2025 Financial Results
Premium
Company Announcements
CorMedix Inc. Reports Strong Q3 2025 Financial Results
2M ago
CRMD
CorMedix Inc. Reports Record Earnings and Strategic Growth
PremiumCompany Announcements
CorMedix Inc. Reports Record Earnings and Strategic Growth
2M ago
CRMD
Cormedix: Buy Rating Affirmed Amid Strong Sales and Future Growth Catalysts
PremiumRatings
Cormedix: Buy Rating Affirmed Amid Strong Sales and Future Growth Catalysts
2M ago
CRMD
CorMedix reports Q3 EPS $1.26, consensus 63c
PremiumThe Fly
CorMedix reports Q3 EPS $1.26, consensus 63c
2M ago
CRMD
CorMedix sees FY25 pro forma revenue $390M-$410M
PremiumThe Fly
CorMedix sees FY25 pro forma revenue $390M-$410M
2M ago
CRMD
Is CRMD a Buy, Before Earnings?
PremiumPre-EarningsIs CRMD a Buy, Before Earnings?
2M ago
CRMD
CorMedix Inc. Advances DEFENCATH® Trial to Combat CLABSIs
Premium
Company Announcements
CorMedix Inc. Advances DEFENCATH® Trial to Combat CLABSIs
3M ago
CRMD
CorMedix Inc. Advances Pediatric Study on DefenCath® for Infection Prevention
Premium
Company Announcements
CorMedix Inc. Advances Pediatric Study on DefenCath® for Infection Prevention
3M ago
CRMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >